Healthy Extracts CEO Highlights Accelerating Growth Through Gummy USA Merger and Technology in Money Channel Interview
Healthy Extracts (OTCQB:HYEX) announced significant developments following its merger with Gummy USA, as discussed by new CEO Don Swanson in a Money Channel interview. The merger integrates Gummy USA's proprietary SureDose™ technology with Healthy Extracts' product development and marketing platform.
The company reported strong financial performance with net revenues up 20% in H1 2025. Notable growth metrics include 88% increase in direct-to-consumer subscriptions and 107% growth in Amazon Subscribe & Save customers. The merger is expected to accelerate growth by over 50% in the coming year.
Healthy Extracts (OTCQB:HYEX) ha annunciato sviluppi significativi dopo la fusione con Gummy USA, come spiegato dal nuovo CEO Don Swanson in un'intervista a Money Channel. La fusione integra la tecnologia proprietaria SureDose™ di Gummy USA con lo sviluppo prodotto e la piattaforma di marketing di Healthy Extracts.
L'azienda ha mostrato una solida performance finanziaria con ricavi netti in crescita del 20% nel primo semestre 2025. Tra i principali indicatori di crescita: l'aumento dell'88% delle sottoscrizioni dirette al consumatore (DTC) e il +107% dei clienti Amazon Subscribe & Save. La fusione dovrebbe accelerare la crescita di oltre più del 50% nel prossimo anno.
Healthy Extracts (OTCQB:HYEX) anunció avances significativos tras su fusión con Gummy USA, según explicó el nuevo CEO Don Swanson en una entrevista con Money Channel. La fusión incorpora la tecnología propietaria SureDose™ de Gummy USA en la plataforma de desarrollo de productos y marketing de Healthy Extracts.
La compañía reportó un sólido desempeño financiero con los ingresos netos crecieron un 20% en el primer semestre de 2025. Entre las métricas de crecimiento destacan un aumento del 88% en sus suscripciones direct-to-consumer y un crecimiento del 107% en los clientes de Amazon Subscribe & Save. Se espera que la fusión acelere el crecimiento en más del 50% en el próximo año.
Healthy Extracts (OTCQB:HYEX)가 Gummy USA와의 합병 이후 중요한 발전을 발표했습니다. 신 CEO Don Swanson이 Money Channel 인터뷰에서 이를 설명했습니다. 합병은 Gummy USA의 독자적 SureDose™ 기술을 Healthy Extracts의 제품 개발 및 마케팅 플랫폼과 통합합니다.
회사는 2025년 상반기 순매출이 20% 증가했다는 강한 재무 실적을 보고했습니다. 주요 성장 지표로는 직접 소비자 구독이 88% 증가하고 아마존 Subscribe & Save 고객이 107% 증가하는 것이 포함됩니다. 합병은 내년 성장률을 50% 이상 가속할 것으로 기대됩니다.
Healthy Extracts (OTCQB:HYEX) a annoncé des avancées significatives après sa fusion avec Gummy USA, comme l’explique le nouveau PDG Don Swanson dans une interview accordée à Money Channel. La fusion intègre la technologie propriétaire SureDose™ de Gummy USA à la plateforme de développement produit et de marketing de Healthy Extracts.
L’entreprise a affiché de solides performances financières avec un chiffre d’affaires net en hausse de 20 % au premier semestre 2025. Parmi les indicateurs de croissance: une augmentation de 88 % des abonnements direct-to-consumer et une croissance de 107 % des clients Amazon Subscribe & Save. La fusion devrait accélérer la croissance de plus de 50 % au cours de l’année à venir.
Healthy Extracts (OTCQB:HYEX) gab bedeutende Entwicklungen nach der Fusion mit Gummy USA bekannt, wie der neue CEO Don Swanson in einem Money Channel-Interview erläuterte. Die Fusion integriert die proprietäre SureDose™-Technologie von Gummy USA in die Produktentwicklung und Marketingplattform von Healthy Extracts.
Das Unternehmen meldete starke finanzielle Leistungen mit Nettoerlösen, die im ersten Halbjahr 2025 um 20% gestiegen sind. Zu den wichtigsten Wachstumskennzahlen gehören eine 88%-ige Zunahme der Direct-to-Consumer-Abonnements und ein 107%-Wachstum der Amazon Subscribe & Save-Kunden. Die Fusion soll das Wachstum im kommenden Jahr um über 50% beschleunigen.
Healthy Extracts (OTCQB:HYEX) أعلنت عن تطورات كبيرة عقب اندماجها مع Gummy USA، كما أوضحها المدير التنفيذي الجديد دون سوانسون في مقابلة مع Money Channel. يدمج الاندماج تكنولوجيا SureDose™ المملوكة لـ Gummy USA مع منصة تطوير المنتجات والتسويق لدى Healthy Extracts.
أفادت الشركة بأداء مالي قوي مع ارتفاع الإيرادات الصافية بنسبة 20% في النصف الأول من 2025. من أبرز مقاييس النمو زيادة الاشتراكات المباشرة للمستهلكين بنسبة 88% و نمو عملاء Amazon Subscribe & Save بنسبة 107%. من المتوقع أن يسرع الاندماج النمو بأكثر من 50% في العام القادم.
Healthy Extracts (OTCQB:HYEX) 宣布在与 Gummy USA 合并后取得重大进展，新任CEO Don Swanson 在 Money Channel 的采访中对此进行了说明。此次合并将 Gummy USA 的专有 SureDose™ 技术 与 Healthy Extracts 的产品开发与营销平台整合。
该公司报告了强劲的财务表现，2025年上半年净收入增长20%。核心增长指标包括 直销订阅增长88% 和 亚马逊 Subscribe & Save 客户增长107%。预计合并将在来年使增长加速超过 50%。
- Merger with Gummy USA expected to accelerate growth by over 50%
- Net revenues increased 20% in first half of 2025
- Direct-to-consumer subscriptions grew 88% year-over-year
- Amazon Subscribe & Save customers increased 107%
- Maintains top three category ranking on Amazon.com
- Integration of proprietary SureDose technology enhances product capabilities
- None.
LAS VEGAS, NV / ACCESS Newswire / September 30, 2025 / The new CEO of Healthy Extracts™ Inc. (OTCQB:HYEX), discussed in an exclusive interview with the Money Channel the company's recent transformative merger with Gummy USA which has accelerated its growth outlook over the coming year by more than
Don Swanson, pioneering manufacturing engineer, founder of Gummy USA and now chairman and CEO of Healthy Extracts, explained how the merger brought together Healthy Extract's powerful product development and marketing platform with his exclusive SureDose™ technology.
The proprietary patent-pending manufacturing technology offers superior safety, efficacy and compliance for commercial customers looking for precision-dosed nutraceutical and pharmaceutical-grade gummies and chewable gels.
Conducted at the ArcStone-Kingswood Growth Summit held last week in Toronto, the interview revealed how Swanson selected Healthy Extracts as his ideal merger partner due to its proven capabilities in the acquisition, development, manufacturing and marketing of science-based nutraceuticals and oral delivery systems. The unique platform has been driving record financial results over the last several quarters, with net revenues up nearly
Much of the growth has been generated by the company's subscription-based recurring revenue streams, with direct-to-consumer product subscriptions increasing
The new precision gummy manufacturing technology complements Healthy Extracts' other exclusive oral delivery technologies that include consumable gels and functional drinking straws.
Swanson also met with key investors at the ArcStone-Kingswood conference, which brought together a select roster of high-growth companies with institutional and retail investors for a full day of presentations and expert-led panel discussions.
The Money Channel interview is viewable online here.
To learn more about Healthy Extracts, visit healthyextractsinc.com.
About The Money Channel
The Money Channel NYC continues to play a defining role in the financial ecosystem. Known for delivering market intelligence through high-impact financial media and investor-focused programming, it provides a platform that amplifies access to capital and investor engagement across sectors. Its team leads initiatives that bridge the gap between issuers and investors, driving visibility and strategic dialogue in today's dynamic market environment. Learn more at www.moneychannelnyc.com.
About Healthy Extracts
Healthy Extracts Inc. (OTCQB:HYEX) develops, manufactures and markets proprietary, science-based supplements for brain, heart, and gut health. The platform enables clinically tested formulas and exclusive partnerships that deliver wellness solutions with measurable consumer and shareholder value.
The company's Gummy USA™ subsidiary is a leading developer and manufacturer of precision-dosed nutraceutical and pharmaceutical-grade gummies. Its proprietary patent-pending SureDose™ technology delivers superior safety, efficacy and compliance for white and private label customers.
Healthy Extracts wholly owned subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical natural heart and brain health supplements. BergametNA products are the only heart health supplements distributed in North America containing Citrus Bergamot SuperFruit™, the only superfruit with the highest known concentration of polyphenols and flavonoids.
The company also has exclusive agreements for other innovative oral delivery systems that include Gelteq gel-packs and the Gut Health Straw, both of which provide superior bioavailability and ultimate consumer convenience.
To learn more, go to: healthyextractsinc.com, bergametna.com, tryubn.com or gummyusa.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on April 1, 2025, and future periodic reports filed with the U.S. Securities and Exchange Commission (SEC). All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only to the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Food & Drug Administration Disclosure
The products mentioned in this press release is not for use by or sale to persons under the age of 12. This product should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor's advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
Gummy USA ™, BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are trademarks and registered trademarks of Healthy Extracts™ Inc.
Company Contact
Healthy Extracts Inc.
Tel (720) 463-1004
Email contact
Investor Contact
CMA Investor Relations
Tel (949) 432-7554
Email contact
SOURCE: HEALTHY EXTRACTS INC.
View the original press release on ACCESS Newswire
FAQ
What is the expected growth impact of Healthy Extracts (HYEX) merger with Gummy USA?
How has Healthy Extracts (HYEX) performed in subscription-based revenue?
What is Healthy Extracts' (HYEX) revenue growth in 2025?
Who is the new CEO of Healthy Extracts (HYEX)?
What is SureDose technology from Healthy Extracts (HYEX)?
